Press ReleasesJanuary 29, 2019
First Patient Dosed with Gene Therapy in Phase 1/2 Study of ACTUS-101 in Patients with Pompe Disease December 14, 2017
Asklepios BioPharmaceutical, Inc. Launches New Portfolio Company – Actus Therapeutics, Inc.
Media CoverageSTAT News February 1, 2017
Scientists Ready to Test Gene Therapy for Pompe Disease
EventsEuropean Society of Gene and Cell Therapy